Fraser John D
SEC Form 4 insider trading activity
Fraser John D has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: May 29, 2026.
On the most recent filing, Fraser John D is listed as Director at Aspira Women's Health Inc. Inside the rolling window, Fraser John D reported 1 open-market purchase totaling $7K in AWHL and no open-market sales.
Companies traded
Other insiders at AWHL
Insider Buying
$7K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Fraser John D made?
Fraser John D has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2025.
Which companies does Fraser John D trade?
Fraser John D has filed SEC Form 4 disclosures for 1 company, including AWHL.
When was Fraser John D's most recent SEC Form 4 filing?
Fraser John D's most recent SEC Form 4 filing on Tracefour is dated May 29, 2026.
What is Fraser John D's total buy and sell value in the current window?
Inside the rolling retention window, Fraser John D bought $7K and sold $0 based on SEC Form 4 filings.
What was Fraser John D's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 16,389 AWHL shares on 2025-09-17, worth $7K, per SEC Form 4 filings.